Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.
Herpes zoster ophthalmicus (HZO), which is a common cause of neurotrophic keratitis (NK), was associated with eye complications and a loss of vision, a study reported. The analysis found older ... Read more
A case study described how a woman with a rare genetic autoimmune disorder developed severe neurotrophic keratitis (NK). Researchers say the case highlights the importance of regular follow-ups and treatment ... Read more
A young boy with neurotrophic keratopathy (NK) caused by a rare congenital disorder was successfully treated with the topical nerve growth factor therapy Oxervate (cenegermin), a case study reports. The treatment ... Read more
Cacicol eye drops safely and effectively healed persistent corneal damage in adults with neurotrophic keratitis (NK) who did not completely respond after two weeks of antibiotic therapy, results of a ... Read more
Activating Src family kinases, a family of enzymes involved in cell migration and growth, enhanced corneal wound healing in cellular and animal models, a preclinical study has found. The findings ... Read more
A non-invasive imaging technique demonstrated that, after eight weeks of treatment, Oxervate eye drops repaired cornea nerve fibers, which are damaged in people with neurotrophic keratitis (NK), according to a ... Read more
A stem cell-based graft therapy using patients’ tissue successfully treated people with severe neurotrophic keratitis, significantly correcting cornea damage and vision in all cases, a pilot study demonstrated. The study, ... Read more